2m 2m 2m 2m 2m 2m 2m
AARDVARK THERA (AARD)
NASDAQ
$4.99-$0.14 (-2.77%)
Price as of Sep 11, 2026 7:56 PM EDT- $112.3MMarket Cap
- -40.28%1-Year Change
- BiotechnologyIndustry
AARDVARK THERA (AARD)
$4.99-$0.14 (-2.77%)
AARD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.13 | ||
Change | +$0.12 (+2.40%) | ||
Open | $5.11 | ||
High | $5.54 | ||
Low | $4.97 | ||
Previous Close | $5.01 | ||
Volume | 276,565 | ||
30-Day Average Volume | 142,478 | ||
1-Week Change | -4.65% | ||
1-Month Change | -28.65% | ||
1-Year Change | -40.28% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 21.9M | ||
Total Assets | $81.5M | ||
Market Cap | $112.3M | ||
Enterprise Value | $38.4M | ||
Period: QTR TTM FY | |||
Revenue | $2,000.00 | ||
Net Income | -$14.4M | ||
Free Cash Flow | -$17.6M | ||
EBIT | -$14.4M | ||
EBITDA | -$14.4M | ||
Net Working Capital | $74.3M | ||
EPS | -$0.66 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 19,210 | ||
P/B | 2 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 2 | ||
Last Split Date | 07/21/2008 | ||
Earnings & Revenue